期刊文献+

老年帕金森病患者血清miR-124、miR-494表达及其临床意义 被引量:4

Expressions and clinical significance of miR-124 and miR-494 in elderly patients with Parkinson disease
原文传递
导出
摘要 目的探讨老年帕金森病(Parkinson disease,PD)患者血清微小RNA-124(miR-124)、微小RNA-494(miR-494)表达水平及其临床意义。方法选取2018年3月~2020年4月在郑州大学附属郑州中心医院住院治疗的90例PD患者(PD组);同期选择在医院体检中心检查且与PD患者年龄、性别相匹配的100名非PD老年人作对照组。所有研究对象空腹12 h后取清晨静脉血4 ml,采用帕金森等级量表(unified Parkinson disease rating scale,UPDRS)对所有PD组患者从精神状态、行为和情感、生活质量、运动检查进行评分,利用帕金森病Hoehn-Yahr分级量表对PD患者进行分级;利用实时荧光定量PCR(qRT-PCR)技术检测血清miR-124和miR-494表达水平;作ROC曲线判断miR-124、miR-494对PD患者的诊断价值。结果UPDRS评分≤60分的PD患者Hoehn-Yahr分级明显低于UPDRS>60分的患者[(2.47±0.43)分,(3.42±0.47)分],差异有统计学意义(t=9.055,P<0.001),但血清miR-124、miR-494表达水平差异无统计学意义[miR-124:(0.72±0.14),(0.70±0.12);miR-494:(1.17±0.19),(1.18±0.22)](t=0.633,0.230,P=0.529,0.819);与对照组相比,PD组血清miR-124表达下调[(0.71±0.20),(1.05±0.24)],miR-494表达上调[(1.18±0.26),(0.96±0.22)](t=10.542,6.315,均P<0.001);ROC曲线结果显示,血清miR-124、miR-494诊断PD的曲线下面积(AUC)分别为0.847,0.760,截断值分别为0.901,1.126,灵敏度分别为86.67%、61.11%,特异度分别为75.03%、79.00%;二者联合诊断PD的AUC为0.898,灵敏度和特异度分别为85.56%、85.00%。结论PD患者血清miR-124呈低表达,miR-494呈高表达,提示二者的水平变化可能与PD的发生、发展有关。二者均对PD有一定的诊断价值,且联合诊断价值更高。 Objective To investigate the expression levels of microRNA-124(miR-124)and microRNA-494(miR-494)in the serum of elderly patients with Parkinson disease(PD)and its clinical significance.Methods Ninety PD patients(PD group)who were hospitalized in Zhengzhou Central Hospital Affiliated to Zhengzhou University from March 2018 to April 2020 were selected.At the same time,100 non-PD elderly people examined in the physical examination center of the same hospital who matched with age and gender of PD patients were selected as the control group.After 12 hours of fasting,4 ml of venous blood was taken from all subjects.All PD patients were graded by unified Parkinson disease rating scale(UPDRS)from the aspects of mental state,behavior and emotion,quality of life and motor examination,and graded by the Hoehn-Yahr rating scale for Parkinson disease.The expression levels of miR-124 and miR-494 in serum were detected by real-time fluorescent quantitative PCR(qRT-PCR),and the diagnostic values of miR-124 and miR-494 in PD patients were evaluated by ROC curve.Results Hoehn-Yahr grade of PD patients with UPDRS≤60 points was significantly lower than that of patients with UPDRS>60 points((2.47±0.43)vs(3.42±0.47))(t=9.055,P<0.001),and there was no significant difference in serum miR-124 and miR-494 expression levels((0.72±0.14)vs(0.70±0.12),(1.17±0.19)vs(1.18±0.22))(t=0.633,0.230,P=0.529,0.819).Compared with that in control group,the expression of miR-124 in PD group was down-regulated((0.71±0.20)vs(1.05±0.24)),and the expression of miR-494 was up-regulated((1.18±0.26)vs(0.96±0.22))(t=10.542,6.315,P<0.001).The results of ROC showed that the area under curve(AUC)of serum miR-124 and miR-494 in the diagnosis of PD were 0.847 and 0.760 respectively,the cutoff values were 0.901 and 1.126,respectively,the sensitivities were 86.67%and 61.11%respectively,and the specificities were 75.03%and 79.00%respectively.The AUC of the combined diagnosis of PD was 0.898,and the sensitivity and specificity were 85.56%and 85.00%respectively.Conclusions The expression of miR-124 is low in PD patients,while the expression of miR-494 is high,which suggests that the changes of the two miRNA levels may be related with the occurrence and development of PD.Both of them have a certain diagnostic value for PD,and the value of combined diagnosis is higher.
作者 李江涛 尹永锋 王润青 张平 赵杰 刘荣丽 陈园园 Li Jiangtao;Yin Yongfeng;Wang Runqing;Zhang Ping;Zhao Jie;Liu Rongli;Chen Yuanyuan(Department of Neurology,Zhengzhou Central Hospital Affiliated to Zhengzhou University,Zhengzhou 450000,China;Department of Neurology,the First Affiliated Hospital of Xinxiang Medical College,Xinxiang 453100,China)
出处 《中华行为医学与脑科学杂志》 CAS CSCD 北大核心 2021年第4期294-298,共5页 Chinese Journal of Behavioral Medicine and Brain Science
基金 河南省医学科技攻关计划项目 (2018020229)。
关键词 帕金森病 老年人 微小RNA-124 微小RNA-494 诊断价值 Parkinson disease Elderly MicroRNA-124 MicroRNA-494 Diagnostic value
  • 相关文献

参考文献7

二级参考文献70

  • 1张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 2Zhang ZX, Roman GC, Hong Z,et al. Parkinson's disease inChina: prevalence in Beijing, Xian, and Shanghai[ J]. Lancet,2005,365(9459): 595-597.
  • 3Postuma RB, Berg D, Stem M, et al. MDS clinical diagnosticcriteria for Parkinson、disease[ J]. Mov Disord, 2015,30( 12):1591-1601. DOI: 10.1002/mds.26424.
  • 4Chaudhuri KR, Healy DG, Schapira AH, et al. Non-motorsymptoms of Parkinson's disease : diagnosis and management[ J ].Lancet Neurol, 2006,5(3): 235-245.
  • 5Goetz CG,Tilley BC, Shaftman SR,et al. Movement DisorderSociety-sponsored revision of the Unified Parkinson; s DiseaseRating Scale ( MDS-UPDRS) . scale presentation and clinimetrictesting results [ J ]. Mov Disord, 2008 , 23 ( 15): 2129-2170.DOI: 10.1002/mds. 22340.
  • 6Shah M, Muhammed N, Findley LJ, et al. Olfactory tests in thediagnosis of essential tremor [ J ]. Parkinsonism Relat Disord,2008,14(7) : 563-568. DOI: 10. 1016/j. parkreldis. 2007. 12.006.
  • 7Wenning GK, Shephard B, Hawkes C, et al. Olfactory functionin atypical parkinsonian syndromes [ J ]. Acta NeurologicaScandinavica, 1995,91(4): 247-250.
  • 8Muller A, Mtingersdorf M, Reichmann H, et al. Olfactoryfunction in Parkinsonian syndromes[ J]. J Clin Neurosci, 2002 , 9(5): 521-524.
  • 9Goldstein DS,Holmes C,Bentho O,et al. Biomarkers to detectcentral dopamine deficiency and distinguish Parkinson diseasefrom multiple system atrophy [ J ]. Parkinsonism Relat Disord,2008,14(8): 600-607. DOI: 10. 1016/j. parkreldis. 2008. 01.010.
  • 10Katzenschlager R, Zijlmans J, Evans A, et al. Olfactory functiondistinguishes vascular parkinsonism from Parkinson's disease[ J].J Neurol Neurosurg Psychiatry, 2004, 75(12) : 1749-1752.

共引文献1192

同被引文献30

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部